159 related articles for article (PubMed ID: 15015776)
1. Inverse correlation between genetic aberrations and malignancy grade in ependymal tumors: a paradox?
Gilhuis HJ; van der Laak J; Wesseling P; Boerman RH; Beute G; Teepen JL; Grotenhuis JA; Kappelle AC
J Neurooncol; 2004 Jan; 66(1-2):111-6. PubMed ID: 15015776
[TBL] [Abstract][Full Text] [Related]
2. Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization.
Scheil S; Brüderlein S; Eicker M; Herms J; Herold-Mende C; Steiner HH; Barth TF; Möller P
Brain Pathol; 2001 Apr; 11(2):133-43. PubMed ID: 11303789
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
4. Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
Carter M; Nicholson J; Ross F; Crolla J; Allibone R; Balaji V; Perry R; Walker D; Gilbertson R; Ellison DW
Br J Cancer; 2002 Mar; 86(6):929-39. PubMed ID: 11953826
[TBL] [Abstract][Full Text] [Related]
5. Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH.
Jeuken JW; Sprenger SH; Gilhuis J; Teepen HL; Grotenhuis AJ; Wesseling P
J Pathol; 2002 Jun; 197(2):238-44. PubMed ID: 12015749
[TBL] [Abstract][Full Text] [Related]
6. [Detection of chromosomal imbalance in ependymoma by comparative genomic hybridization].
Wu WX; Yu SZ; Sun CY; Wang Q; Jin SM; An TL
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):148-52. PubMed ID: 19575847
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.
Hirose Y; Aldape K; Bollen A; James CD; Brat D; Lamborn K; Berger M; Feuerstein BG
Am J Pathol; 2001 Mar; 158(3):1137-43. PubMed ID: 11238062
[TBL] [Abstract][Full Text] [Related]
8. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY
J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800
[TBL] [Abstract][Full Text] [Related]
9. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
10. 9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases.
Rajaram V; Leuthardt EC; Singh PK; Ojemann JG; Brat DJ; Prayson RA; Perry A
Mod Pathol; 2004 Jan; 17(1):9-14. PubMed ID: 14631364
[TBL] [Abstract][Full Text] [Related]
11. Genomic characterization of ependymomas reveals 6q loss as the most common aberration.
Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P
Oncol Rep; 2014 Aug; 32(2):483-90. PubMed ID: 24939246
[TBL] [Abstract][Full Text] [Related]
12. Analysis of chromosome 7 in adult and pediatric ependymomas using chromogenic in situ hybridization.
Santi M; Quezado M; Ronchetti R; Rushing EJ
J Neurooncol; 2005 Mar; 72(1):25-8. PubMed ID: 15803371
[TBL] [Abstract][Full Text] [Related]
13. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.
Korshunov A; Neben K; Wrobel G; Tews B; Benner A; Hahn M; Golanov A; Lichter P
Am J Pathol; 2003 Nov; 163(5):1721-7. PubMed ID: 14578171
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of histopathological ependymoma variants.
Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
[TBL] [Abstract][Full Text] [Related]
15. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
16. Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.
Rajaram V; Gutmann DH; Prasad SK; Mansur DB; Perry A
Mod Pathol; 2005 Jul; 18(7):991-7. PubMed ID: 15731777
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
[TBL] [Abstract][Full Text] [Related]
18. Spinal cord ependymomas in children and adolescents.
Benesch M; Frappaz D; Massimino M
Childs Nerv Syst; 2012 Dec; 28(12):2017-28. PubMed ID: 22961356
[TBL] [Abstract][Full Text] [Related]
19. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for partially resected spinal ependymomas: a retrospective study of 60 cases.
Gilhuis HJ; Kappelle AC; Beute G; Wesseling P; Grotenhuis A; Boerman RH
Oncol Rep; 2003; 10(6):2079-82. PubMed ID: 14534747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
